ReviewDiabetes care2025
7. Diabetes Technology: Standards of Care in Diabetes-2025.
Review in Diabetes care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 175 papers, 7 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
175 citing papers in PubMed, 7 syntheses or guidelines pooled it.
- Continuous glucose monitoring in type 2 diabetes: Evidence for glycaemic metrics and patient-reported outcomes.Diabetic medicine : a journal of the British Diabetic Association · 2026Pooled it
- Evidence-based recommendations for the use of continuous glucose monitoring in type 2 diabetes: the Italian guidelines.Acta diabetologica · 2026Guideline
- Glycaemic control and variability with different commercially available hybrid closed loop systems in people with type 1 diabetes: A systematic review and meta-analysis of randomized controlled trials.Diabetes, obesity & metabolism · 2026Pooled it
- A systematic literature review and meta-analysis of real-world evidence on commercially available automated insulin delivery systems in people with type 1 diabetes.Diabetes, obesity & metabolism · 2026Pooled it
- The effect of continuous glucose monitoring on neonatal outcomes in pregnant women with diabetes.Frontiers in endocrinology · 2026Pooled it
- The therapeutic efficacy of continuous glucose monitoring in diabetes: an updated meta-analysis with meta-regression.Endocrine · 2025Pooled it
- Continuous glucose monitoring in noninsulin-treated type 2 diabetes: A critical review of reported trials with an updated systematic review and meta-analysis of randomised controlled trials.Diabetes, obesity & metabolism · 2025Pooled it
- Community-Based Personalised Lifestyle Intervention Guided by Intermittent Continuous Glucose Monitoring in Adults With Type 2 Diabetes: A Multicentre Randomised Controlled Trial.Diabetes, obesity & metabolism · 2026Trial
- A pilot trial of 'HypoPals': Assessing trial procedures feasibility and intervention acceptability for a prospective digital hypoglycemia behavioral intervention study.Contemporary clinical trials · 2026Trial
- Trial
- Rapid improvements in glycemic management with use of continuous glucose monitoring in adults with type 2 diabetes treated with basal insulin: 3-month analysis of the MOBILE study.BMJ open diabetes research & care · 2025Trial
- β-Cell Function Derived From Routine Clinical Measures Reports and Predicts Treatment Response to Immunotherapy in Recent-Onset Type 1 Diabetes.Diabetes care · 2025Trial
- Real-time continuous glucose monitoring in adults with type 2 diabetes managed with non-intensive insulin regimens: impact on glycemia and self-management.Journal of diabetes and metabolic disorders · 2026Article
- Insulin pens and the digital ecosystem.Diabetologia · 2026Review
- Bridging Technology and Care: Advancing Diabetes Management for Preschool Children in Philippine Schools.Journal of diabetes science and technology · 2026Article
- Temporal Distribution of Elevated-HbA1c Records and a Young-Adult Multiorgan Biomarker Profile in Diabetes: A Retrospective Observational Study.Diseases (Basel, Switzerland) · 2026Article
- Pediatric Inpatient Continuous Glucose Monitoring: Development and Implementation of a Hospital Policy for Accuracy-Validated Insulin Dosing.Diabetes technology & therapeutics · 2026Article
- Evaluation of continuous glucose monitoring outcomes and health care resource utilization in patients with non-insulin-treated type 2 diabetes.Journal of managed care & specialty pharmacy · 2026Article
- Knowledge, attitude and practice on continuous glucose monitoring and self-monitoring of blood glucose among healthcare professionals across India: A cross-sectional study.TouchREVIEWS in endocrinology · 2026Article
- AI-Assisted Nutrition Estimation and Exercise Support for Integrated Lifestyle Management in Patients with Diabetes.Nutrients · 2026Article
115 more citing papers are in PubMed but not listed here.
Corrections and comments
- Erratum issued
Authors and funding
1 author.
Funding
Abstract
The American Diabetes Association (ADA) "Standards of Care in Diabetes" includes the ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, an interprofessional expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations and a full list of Professional Practice Committee members, please refer to Introduction and Methodology. Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.